Atlas Trials

Himalaya Early Access Program

Clinical trial NCT05345678 · APPROVED_FOR_MARKETING

Trial details

NCT number
NCT05345678
Sponsor
AstraZeneca
Status
APPROVED_FOR_MARKETING
Study type
EXPANDED_ACCESS
Unresectable Hepatocellular Carcinoma

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.